Effect of Statin Therapy on C-Reactive Protein Levels

Michelle A. Albert; Ellie Danielson; Nader Rifai; Paul M. Ridker; for the PRINCE Investigators

doi:10.1001/jama.286.1.64

Abstract

In this prospective trial, pravastatin reduced CRP levels at both 12 and 24 weeks in a largely LDL-C-independent manner. These data provide evidence that statins may have anti-inflammatory effects in addition to lipid-lowering effects.

Keywords

PravastatinMedicineC-reactive proteinInternal medicineStatinPlaceboCohortProspective cohort studyCholesterolInflammationPathology

Affiliated Institutions

Related Publications

Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

Paul M. Ridker , Nader Rifai , Marc A. Pfeffer +2 more

Background —Elevated plasma concentrations of C-reactive protein (CRP) are associated with increased cardiovascular risk. We evaluated whether long-term therapy with pravastatin...

1999 Circulation 1472 citations

C-Reactive Protein Levels and Outcomes after Statin Therapy

Paul M. Ridker , Christopher P. Cannon , David A. Morrow +5 more

Patients who have low CRP levels after statin therapy have better clinical outcomes than those with higher CRP levels, regardless of the resultant level of LDL cholesterol. Stra...

2005 New England Journal of Medicine 2272 citations

Lipoprotein-Associated Phospholipase A <sub>2</sub> , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study

Christie M. Ballantyne , Ron C. Hoogeveen , Heejung Bang +4 more

Background— Measuring C-reactive protein (CRP) has been recommended to identify patients at high risk for coronary heart disease (CHD) with low LDL cholesterol (LDL-C). Lipoprot...

2004 Circulation 613 citations

Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT

Erin A. Bohula , Robert P. Giugliano , Christopher P. Cannon +6 more

Background— Statins lower low-density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (hs-CRP); addition of ezetimibe to statins further reduces LDL-C an...

2015 Circulation 327 citations

Inflammation and Atherosclerosis

Peter Libby , Paul M. Ridker , Attilio Maseri

Atherosclerosis, formerly considered a bland lipid storage disease, actually involves an ongoing inflammatory response. Recent advances in basic science have established a funda...

2002 Circulation 7564 citations

Publication Info

Year: 2001
Type: article
Volume: 286
Issue: 1
Pages: 64-64
Citations: 1641
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effect of Statin Therapy on C-Reactive Protein Levels

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1641

OpenAlex

Cite This

APA Style

                            
                                
                                    Michelle A. Albert, 
                                
                                    Ellie Danielson, 
                                
                                    Nader Rifai
                                
                                et al.
                            
                            (2001). 
                            Effect of Statin Therapy on C-Reactive Protein Levels. 
                            JAMA
                            , 286
                            (1)
                            , 64-64.
                            https://doi.org/10.1001/jama.286.1.64
                        

Identifiers

DOI: 10.1001/jama.286.1.64